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Conclusions: GTV shrinkage of rectal tumors treated with 
neoadjuvant chemoradiotherapy already occurs in the first 
two weeks of treatment and continues up to 7 weeks post-
treatment. The observed volume reduction during treatment 
suggests a benefit for a sequential boost on the remaining 
tumor after CRT or for volume adaptation in case of a 
simultaneous integrated boost.  
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Purpose/Objective: Advances in small animal radiotherapy 
enable the delivery of increasingly complex heterogeneous 
dose distributions on the millimeter scale, but methods to 
plan complicated small animal treatments remain in their 
infancy. A pre-clinical irradiation plan is usually created 
based on cone beam CT data with the animal in treatment 
position under anesthesia. Combined with demands on 
throughput, fast and easy treatment planning methods and 
algorithms are required. The purpose of this study is to 
develop an optimization model that determines beam-on 
times for a given beam configuration, and to assess the 
benefits of automated treatment planning for small animal 
radiotherapy. 
Materials and Methods: The applied model determines a 
Pareto-optimal solution based on user-provided weights for 
objectives. An interactive approach allows the user to select 
the plan that yields the most preferred trade-offs. Two cases 
based on cone beam CT data of a rat were used, and manual 
and model-based optimization results were compared using 
dose-volume metrics. The kidneys, spine and gastrointestinal 
tract (GI) were delineated as organs at risk (OARs) and a 
fictitious planning target volume (PTV) was created around 
the spine. In case 1, the left kidney was targeted as PTV with 
four 10x10 mm2 beams and for case 2, twelve 8x10 mm2 
beams were used to target the PTV around the spine. A PTV 
dose of 8 Gy was prescribed, with a mean dose between 8 
and 10 Gy as constraint. Differences between prescribed and 
planned PTV dose, as well as OAR doses were included in 
penalty objectives. The model was integrated in a research 
version of Monte Carlo based small animal treatment 
planning system SmART-Plan (v2.0 Precision X-ray). 
Results: Results show that manual and automated treatment 
planning yields plans of similar quality as shown in the figure 
and table. A similar amount of time was needed for manual 
and model-based optimization. In this period, manual 
optimization generates a single plan, while a set of Pareto-
optimal plans is created with automated optimization, 
allowing for a more substantiated choice on trade-offs. 
Automated optimization often uses fewer beams than manual 
optimized plans, therewith lowering treatment delivery time. 
Additional benefits of automated planning include a 
decreased dependence on the planning skills of the user 
(often absent in pre-clinical research), and the potential to 
improve treatment standardization among institutions. For 
more complex irradiations, manual planning becomes 
infeasible, making automation a necessity. 
 
Conclusions: Automation of treatment planning offers 
benefits to optimize plan quality in the short available time 
for treatment planning, to decrease dependence on user 
skills, to give more insight in trade-offs, and to improve 
standardization. The interactive Pareto-optimization 
framework was be able to produce plans of good quality, and 
allows for extension to full inverse treatment planning.  
 
